GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 90 filers reported holding GENMARK DIAGNOSTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,961,000 | +4.1% | 160,182 | +0.4% | 0.00% | 0.0% |
| Q3 2016 | $1,883,000 | +40.4% | 159,599 | +3.6% | 0.00% | 0.0% |
| Q2 2016 | $1,341,000 | +69.3% | 154,094 | +2.6% | 0.00% | +100.0% |
| Q1 2016 | $792,000 | -30.7% | 150,195 | +1.9% | 0.00% | 0.0% |
| Q4 2015 | $1,143,000 | -0.9% | 147,358 | +0.6% | 0.00% | -50.0% |
| Q3 2015 | $1,153,000 | -15.3% | 146,524 | -2.5% | 0.00% | 0.0% |
| Q2 2015 | $1,362,000 | -13.6% | 150,283 | +23.8% | 0.00% | 0.0% |
| Q1 2015 | $1,576,000 | -3.8% | 121,391 | +0.8% | 0.00% | 0.0% |
| Q4 2014 | $1,639,000 | +50.9% | 120,396 | -0.5% | 0.00% | 0.0% |
| Q3 2014 | $1,086,000 | -32.8% | 121,021 | +1.2% | 0.00% | 0.0% |
| Q2 2014 | $1,617,000 | +63.8% | 119,531 | +20.4% | 0.00% | +100.0% |
| Q1 2014 | $987,000 | -23.8% | 99,276 | +1.9% | 0.00% | -50.0% |
| Q4 2013 | $1,295,000 | +7.4% | 97,467 | -1.9% | 0.00% | 0.0% |
| Q3 2013 | $1,206,000 | +54.4% | 99,369 | +31.7% | 0.00% | +100.0% |
| Q2 2013 | $781,000 | – | 75,437 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|